Form 4: Integra Lifesciences Director Awarded RSUs

Director Renee Wonlai Lo received a grant of 17,700 restricted stock units (RSUs) from Integra Lifesciences Holdings Corp.

Summary

• Renee Wonlai Lo, a Director at Integra Lifesciences Holdings Corp. (IART), was granted 17,700 restricted stock units (RSUs) on May 7, 2026.
• These RSUs are part of the company's Fifth Amended and Restated 2003 Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of IART common stock.
• The RSUs will vest in full on the one-year anniversary of the grant date, which is May 7, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director rather than a significant financial or strategic development.

Positives

• Director Renee Wonlai Lo received a significant grant of 17,700 restricted stock units, indicating continued investment in key personnel.
• The grant is part of an established equity incentive plan, suggesting a structured approach to employee and director compensation.
• The RSUs vest in full after one year, providing a clear incentive for continued service and performance.

Future Outlook

The filing indicates a future vesting event for the granted RSUs on May 7, 2027, which is contingent on continued service.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to directors are a common practice in the life sciences industry to align executive interests with shareholder value and retain talent.

Stakeholder Impact

• Shareholders: The grant of RSUs represents a form of compensation, which can impact dilution if shares are issued upon vesting. However, it also serves to incentivize director performance.
• Directors: Renee Wonlai Lo benefits directly from this equity grant, aligning her interests with the company's long-term performance.
• Employees: The filing pertains to director compensation and does not directly impact other employees, though it reflects the company's overall compensation philosophy.

Next Steps

• Vesting of 17,700 RSUs on May 7, 2027, subject to continued service.
• Potential issuance of 17,700 shares of common stock upon vesting.

Key Dates

Keywords

Form 4, SEC Filing, Integra Lifesciences Holdings Corp, IART, Renee Wonlai Lo, Restricted Stock Units, RSUs, Equity Incentive Plan, Director Compensation, Stock Grant